- Previous Close
51.40 - Open
51.40 - Bid 49.80 x --
- Ask 50.00 x --
- Day's Range
49.50 - 51.40 - 52 Week Range
24.70 - 55.00 - Volume
10,866 - Avg. Volume
21,594 - Market Cap (intraday)
1.439B - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
65.13 - EPS (TTM)
0.76 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. EQL Pharma AB (publ) was incorporated in 2006 and is based in Lund, Sweden.
www.eqlpharma.com21
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: EQL.ST
Performance Overview: EQL.ST
Trailing total returns as of 6/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EQL.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EQL.ST
Valuation Measures
Market Cap
1.49B
Enterprise Value
1.60B
Trailing P/E
67.63
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.80
Price/Book (mrq)
8.41
Enterprise Value/Revenue
6.06
Enterprise Value/EBITDA
46.66
Financial Highlights
Profitability and Income Statement
Profit Margin
8.60%
Return on Assets (ttm)
6.18%
Return on Equity (ttm)
13.66%
Revenue (ttm)
264.17M
Net Income Avi to Common (ttm)
22.7M
Diluted EPS (ttm)
0.76
Balance Sheet and Cash Flow
Total Cash (mrq)
20.47M
Total Debt/Equity (mrq)
67.57%
Levered Free Cash Flow (ttm)
-97.81M